FI921111A0 - Konjugatvaccin mot strepto- kocker av typ b. - Google Patents

Konjugatvaccin mot strepto- kocker av typ b.

Info

Publication number
FI921111A0
FI921111A0 FI921111A FI921111A FI921111A0 FI 921111 A0 FI921111 A0 FI 921111A0 FI 921111 A FI921111 A FI 921111A FI 921111 A FI921111 A FI 921111A FI 921111 A0 FI921111 A0 FI 921111A0
Authority
FI
Finland
Prior art keywords
kocker
conjugatvaccin
strepto
mot
type
Prior art date
Application number
FI921111A
Other languages
English (en)
Other versions
FI105154B (fi
Inventor
James L Michel
Dennis L Kasper
Frederick M Ausubel
Original Assignee
Gen Hospital Corp
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp, Brigham & Womens Hospital filed Critical Gen Hospital Corp
Publication of FI921111A0 publication Critical patent/FI921111A0/fi
Application granted granted Critical
Publication of FI105154B publication Critical patent/FI105154B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI921111A 1989-09-15 1992-03-13 Menetelmä konjugaattirokotteen valmistamiseksi B-ryhmän streptokokkeja vastaan FI105154B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40803689A 1989-09-15 1989-09-15
US40803689 1989-09-15
US9005251 1990-09-14
PCT/US1990/005251 WO1991004049A1 (en) 1989-09-15 1990-09-14 CONJUGATE VACCINE FOR GROUP B $i(STREPTOCOCCUS)

Publications (2)

Publication Number Publication Date
FI921111A0 true FI921111A0 (fi) 1992-03-13
FI105154B FI105154B (fi) 2000-06-30

Family

ID=23614587

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921111A FI105154B (fi) 1989-09-15 1992-03-13 Menetelmä konjugaattirokotteen valmistamiseksi B-ryhmän streptokokkeja vastaan

Country Status (22)

Country Link
EP (1) EP0491865B1 (fi)
JP (2) JPH05500455A (fi)
KR (1) KR0180559B1 (fi)
AT (1) ATE146081T1 (fi)
AU (1) AU641439B2 (fi)
CA (2) CA2383393A1 (fi)
DE (1) DE69029396T2 (fi)
DK (1) DK0491865T3 (fi)
ES (1) ES2097154T3 (fi)
FI (1) FI105154B (fi)
GR (1) GR1002294B (fi)
HU (1) HU219327B (fi)
IE (1) IE903349A1 (fi)
IL (1) IL95578A (fi)
NO (1) NO313908B1 (fi)
NZ (1) NZ235316A (fi)
PL (3) PL168587B1 (fi)
PT (1) PT95316A (fi)
RU (1) RU2113234C1 (fi)
WO (1) WO1991004049A1 (fi)
YU (1) YU176490A (fi)
ZA (1) ZA907297B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
IL107103A (en) * 1992-09-24 2001-03-19 Brigham & Womens Hospital A multi-valued vaccine based on an attached molecule containing a capsular polysaccharide attached to a protein and a method for preparing this special molecule
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
IL107458A0 (en) * 1992-11-02 1994-02-27 Gen Hospital Corp Conjugate vaccine against group b streptococcus
AU722078B2 (en) * 1992-11-02 2000-07-20 Brigham And Women's Hospital Conjugate vaccine against group B Streptococcus
CA2158658A1 (en) * 1993-03-19 1994-09-29 Margaretha Stalhammar-Carlemalm Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
AU755343B2 (en) * 1997-12-31 2002-12-12 Montana State University-Bozeman A method of isolating a peptide which immunologically mimics microbial carbohydrates including group B streptococcal carbohydrates and the use thereof in a vaccine
CA2591510A1 (en) * 2004-12-22 2006-06-29 Novartis Vaccines And Diagnostics, Inc. Group b streptococcus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367222A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Immune globulin specific to Group B streptococci
US4367223A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Vaccine against Group B streptococci
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
NZ214503A (en) * 1984-12-20 1990-02-26 Merck & Co Inc Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
EP0302887B1 (en) * 1986-04-16 1994-06-22 The Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines, and methods of manufacture
EP0419462A4 (en) * 1987-07-17 1991-07-17 Xoma Corporation Improved immunotoxin therapies utilizing purified ricin a-chain species

Also Published As

Publication number Publication date
KR920703097A (ko) 1992-12-17
JP2001309795A (ja) 2001-11-06
DE69029396T2 (de) 1997-06-05
GR1002294B (el) 1996-05-03
RU2113234C1 (ru) 1998-06-20
YU176490A (sh) 1992-12-21
AU641439B2 (en) 1993-09-23
JP3447713B2 (ja) 2003-09-16
GR900100692A (el) 1992-01-20
AU6519090A (en) 1991-04-18
DE69029396D1 (de) 1997-01-23
NO920942D0 (no) 1992-03-11
DK0491865T3 (da) 1997-06-02
ATE146081T1 (de) 1996-12-15
PL167882B1 (pl) 1995-11-30
NZ235316A (en) 1992-11-25
ZA907297B (en) 1993-06-01
NO920942L (no) 1992-05-12
EP0491865A1 (en) 1992-07-01
ES2097154T3 (es) 1997-04-01
NO313908B1 (no) 2002-12-23
PT95316A (pt) 1991-06-25
PL286898A1 (en) 1991-06-03
FI105154B (fi) 2000-06-30
IL95578A0 (en) 1991-06-30
HUT63770A (en) 1993-10-28
PL167444B1 (pl) 1995-09-30
KR0180559B1 (ko) 1999-03-20
JPH05500455A (ja) 1993-02-04
HU219327B (en) 2001-03-28
PL168587B1 (pl) 1996-03-29
EP0491865B1 (en) 1996-12-11
WO1991004049A1 (en) 1991-04-04
CA2383393A1 (en) 1991-04-04
CA2066221C (en) 2002-07-23
IL95578A (en) 1998-08-16
IE903349A1 (en) 1991-04-10
CA2066221A1 (en) 1991-03-16
EP0491865A4 (en) 1993-05-05

Similar Documents

Publication Publication Date Title
FI921111A0 (fi) Konjugatvaccin mot strepto- kocker av typ b.
IT1236688B (it) Procedimento e dispositivo per la creazione di una miscela combustibile-aria comburente da addurre a una combustione.
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
DK0549617T3 (da) Forbedrede vaccinepræparater
DE69233287D1 (de) Gereinigte chitindeacetylase
PT84586B (pt) Aperfeicoamentos nas guarnicoes de portas e janelas
DE69119074D1 (de) Kovalente-ther lipidnukleosid-konjugate
DE69534992D1 (de) Mutierendes enterotoxin als nichttoxisches orales adjuvans
FI19991917A (fi) Parannettu meningokokki-polysakkaridikonjugaattirokote
DE3869872D1 (de) Lyophilisierte pharmazeutische zubereitung eines neocarzinostatinderivates.
SE8600998L (sv) Parenterala fenytoinpreparat
PT1042340E (pt) Oxima de 6-o-alquil-eritromicina b
KR900001357A (ko) 착색을 방지하는 외용제
AU3204489A (en) A synthetic antigen evoking anti-hiv response
IT1222518B (it) Anticorpi monoclonali e peptidi utili a trattare e diagnosticare infezione da hiv
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
SE8202439L (sv) 4'-jodderivat av antracyklinglykosider
WO1994010317A3 (en) Conjugate vaccine against group b streptococcus
IT1076278B (it) Apparecchio depuratore d'aria,sepcialmente cappa aspirante da applicare al disopra di cucine e simili
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
FR2631626B1 (fr) Nouveaux pentapeptides et leurs applications en tant que medicaments, notamment antithrombotiques
FI901459A0 (fi) In vitro-syntes av ingripande rna.
GR890100007A (el) Θεραπεία χολερυ?ρίνης απο του στόματος.
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов

Legal Events

Date Code Title Description
MA Patent expired